This project focuses on the development of dormant nanoparticles that activate in response to specific biochemical signals, such as those associated with the reactivation of HSV-1 or the presence of disease markers in cancer. These nanoparticles deliver targeted therapies to neutralize viruses or target diseased cells before symptoms appear.
-
Updated
Sep 12, 2024